Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Arthritis & Rheumatology (Hoboken, N.J.)|May 29, 2018
Association of Abnormal Elevations in IFIT3 With Overactive Cyclic GMP-AMP Synthase/Stimulator of Interferon Genes Signaling in Human Systemic Lupus Erythematosus MonocytesJiehua Wang, Min Dai, Yange Cui, et al.
Clinical & Translational Immunology|June 7, 2021
Sustained low-dose interleukin-2 therapy alleviates pathogenic humoral immunity via elevating the Tfr/Tfh ratio in lupusKaili Liang, Jing He, Yunbo Wei, et al.
The EMBO Journal|February 22, 2022
AKT2 reduces IFNβ1 production to modulate antiviral responses and systemic lupus erythematosusXin Zheng, Jun Xiao, Qi Jiang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 19, 2025
Trio whole exome sequencing in Chinese childhood-onset lupus reveals novel candidate genesJianyang Ma, Yuting Qin, Soon-Min Hong, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2022
Integrative Functional Genomics Identifies Systemic Lupus Erythematosus Causal Genetic Variant in the IRF5 Risk LocusGuojun Hou, Tian Zhou, Ning Xu, et al.
Frontiers in Immunology|May 28, 2019
Identification of Renal Long Non-coding RNA RP11-2B6.2 as a Positive Regulator of Type I Interferon Signaling Pathway in Lupus NephritisZhuojun Liao, Zhizhong Ye, Zhixin Xue, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 9, 2023
De Novo PACSIN1 Gene Variant Found in Childhood Lupus and a Role for PACSIN1/TRAF4 Complex in Toll-like Receptor 7 ActivationChengmei Xie, Haibo Zhou, Vicki Athanasopoulos, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 20, 2023
The Oxysterol Receptor EBI2 Links Innate and Adaptive Immunity to Limit IFN Response and Systemic Lupus ErythematosusFang Zhang, Baokai Zhang, Huihua Ding, et al.
The Journal of Clinical Investigation|January 4, 2022
The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responsesSamantha A Chalmers, Rajalakshmy Ayilam Ramachandran, Sayra J Garcia, et al.
Nature Communications|January 9, 2021
SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expressionGuojun Hou, Isaac T W Harley, Xiaoming Lu, et al.
Pageof 7